Search Results - "IKEZAWA, H"

DEVELOPMENT OF MULTI-VIEW STEREO CONSIDERING ACCURACY OF EXTERIOR ORIENTATION ELEMENTS by Fuse, T., Ikezawa, H.

“…Structure from motion (SfM) has been widely used to achieve automatic 3D reconstructions. However, as the 3D point clouds obtained via SfM are sparse,…”
Get full text

The results of modified distraction arthroplasty for degenerated osteoarthritis of the ankle by Usami, N., V, Ikezawa, H

Get full text

Eribulin as first- or second-line chemotherapy for advanced or metastatic HER2-negative breast cancer: A real-world prospective study by Takahashi, M., Inoue, K., Mukai, H., Yamanaka, T., Egawa, C., Sakata, Y., Ikezawa, H., Matsuoka, T., Tsurutani, J.

Get full text

Mid and long term clinical results of dorsiflexion osteotomy of the first metatarsal bone for hallux rigidus by Ikezawa, H, Usami, N, Suda, Y, Toyama, Y

Get full text

Progress of superconducting bearing technologies for flywheel energy storage systems by Koshizuka, N., Ishikawa, F., Nasu, H., Murakami, M., Matsunaga, K., Saito, S., Saito, O., Nakamura, Y., Yamamoto, H., Takahata, R., Itoh, Y., Ikezawa, H., Tomita, M.

“…We report present status of NEDO project on “Superconducting bearing technologies for flywheel energy storage systems”. We fabricated a superconducting…”
Get full text

Present status of R & D on superconducting magnetic bearing technologies for flywheel energy storage system by Koshizuka, N, Ishikawa, F, Nasu, H, Murakami, M, Matsunaga, K, Saito, S, Saito, O, Nakamura, Y, Yamamoto, H, Takahata, R, Oka, T, Ikezawa, H, Tomita, M

“…We report on the NEDO project of superconducting magnetic bearing (SMB) technologies for flywheel energy storage system. We fabricated SMB modules which…”
Get full text

1683POne-year follow-up results of eribulin for soft-tissue sarcoma including rare subtypes in a real-world observational study in Japan by Takahashi, S, Megumi, Y, Sakata, Y, Ikezawa, H, Matsuoka, T, Kawai, A

“…Abstract Background Eribulin mesylate (ERI) has received approval in Japan for the treatment of soft-tissue sarcomas (STSs). However, efficacy and safety data…”
Get full text

One-year follow-up results of eribulin for soft-tissue sarcoma including rare subtypes in a real-world observational study in Japan by Takahashi, S., Megumi, Y., Sakata, Y., Ikezawa, H., Matsuoka, T., Kawai, A.

Get full text

1683P - One-year follow-up results of eribulin for soft-tissue sarcoma including rare subtypes in a real-world observational study in Japan by Takahashi, S., Megumi, Y., Sakata, Y., Ikezawa, H., Matsuoka, T., Kawai, A.

“…Eribulin mesylate (ERI) has received approval in Japan for the treatment of soft-tissue sarcomas (STSs). However, efficacy and safety data for ERI treatment of…”
Get full text

A distant evolutionary relationship between bacterial sphingomyelinase and mammalian DNase I by Matsuo, Yo, Yamada, Atsuko, Tsukamoto, Kikuo, Tamura, Hiro‐Omi, Ikezawa, Hiroh, Nakamura, Haruki, Nishikawa, Ken

“…The three‐dimensional structure of bacterial sphingomyelinase (SMase) was predicted using a protein fold recognition method; the search of a library of known…”
Get full text

719P Correlative serum biomarker analyses: Lenvatinib (LEN) plus pembrolizumab (PEMBRO) in a phase Ib/II trial in advanced renal cell carcinoma (RCC) by Lee, C-H., Adachi, Y., Ikezawa, H., Li, S.D., Funahashi, Y., Minoshima, Y., Kubiak, P., Perini, R., Ren, M., Smith, A.D., Motzer, R.J.

Get full text

545P First-in-human (FIH) study of E7130 in patients (pts) with advanced solid tumors: Primary result of dose-escalation part by Doi, T., Matsubara, N., Naito, Y., Kuboki, Y., Harano, K., Ono, M., Urasaki, T., Ohmoto, A., Hisai, T., Mikubo, A., Ikezawa, H., Shiba, S., Ito, K., Asano, O., Takahashi, S.

Get full text

Prospective observational study of peripheral neuropathy in breast cancer patients treated with eribulin by Sakata, Y., Iwata, H., Ikezawa, H., Fudetani, R., Tonoda, D., Uchida, Y., Hasegawa, H., Matsuoka, T.

Get full text

314PEribulin as first- or second-line chemotherapy for advanced or metastatic HER2-negative breast cancer: A real-world prospective study by Takahashi, M, Inoue, K, Mukai, H, Yamanaka, T, Egawa, C, Sakata, Y, Ikezawa, H, Matsuoka, T, Tsurutani, J

Get full text

Spectrum of pathological conditions of posterior ankle impingement due to ballet dancing by Hiraishi, E., Ikezawa, H., Usami, N.

Get full text

Characterization and Cloning of an Extremely Thermostable, Pyrococcus furiosus-Type 4Fe Ferredoxin from Thermococcus profundus by Imai, Takeo, Tagucbi, Katsuhiko, Ogawara, Yoko, Ohmori, Daijiro, Yamakura, Fumiyuki, Ikezawa, Hidenori, Urushiyama, Akio

“…An extremely thermostable [4Fe-4S] ferredoxin was isolated under anaerobic conditions from a hyperthermophilic archaeon Thermococcus profundus, and the…”
Get full text

Glycosylphosphatidylinositol (GPI)-Anchored Proteins by Ikezawa, Hiroh

“…From the numerous studies developed at the last quarter of the 20th century, glycosylphosphatidylinositol (GPI) anchor has been established as a unique mode of…”
Get full text

421P A multicenter, randomized, double-blind, placebo (PBO)-controlled, phase III trial of lenvatinib (LEN) in patients (pts) with radioiodine-refractory differentiated thyroid cancer (RR-DTC) in China by Gao, M., Ge, M., Xu, Z., Ji, Q., Shi, F., Qin, J., Wang, F., Chen, G., Zhang, Y., Huang, R., Tan, J., Huang, T., Li, S., Lv, Z., Lin, Y., Guo, Z., Kubota, T., Suzuki, T., Ikezawa, H., Zheng, X.

Get full text

17O A first-in-human phase I study of MORAb-202 in patients with folate receptor alpha-positive advanced solid tumors by Sato, J., Shimizu, T., Fujiwara, Y., Yonemori, K., Koyama, T., Shimomura, A., Tamura, K., Iwasa, S., Kondo, S., Sudo, K., Ikezawa, H., Nomoto, M., Nakajima, R., Miura, T., Yamamoto, N.

Get full text

Mutation in aspartic acid residues modifies catalytic and haemolytic activities of Bacillus cereus sphingomyelinase by Tamura, H, Tameishi, K, Yamada, A, Tomita, M, Matsuo, Y, Nishikawa, K, Ikezawa, H

“…Four aspartic acid residues (Asp126, Asp156, Asp233 and Asp295) of Bacillus cereus sphingomyelinase (SMase) in the conservative regions were changed to glycine…”
Get full text